Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: A meta-analysis

Journal of the American Medical Association

Volumn 278, Issue 16, 1997, Pages 1349-1356

  Farrer, Lindsay A ^a   Cupples, L Adrienne ^a   Haines, Jonathan L ^b,h   Hyman, Bradley ^b   Kukull, Walter A ^c   Mayeux, Richard ^d   Myers, Richard H ^a   Pericak Vance, Margaret A ^e   Risch, Neil ^f   Van Duijn, Cornelia M ^g  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^h Athena Neurosciences Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

ADULT; AGE; AGED; ALZHEIMER DISEASE; CONTROLLED STUDY; DEMENTIA; ETHNIC DIFFERENCE; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE;

EID: 0030823158     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.278.16.1349     Document Type: Review

References (85)

1. Goate A, Chartier-Harlin M-C, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991;349:704-706.
2. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 1995;375: 754-760.
3. Levy-Lahad E, Wasco W, Poorkaj P, et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 1995;269:973-977.
4. Farrer LA. Genetics and the dementia patient. Neurologist. 1997;3:13-30.
5. Zannis VI, Kardassis D, Zannis EE. Genetic mutations affecting human lipoproteins, their receptors, and their enzymes. Adv Hum Genet. 1993;21: 145-319.
6. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993;90:1977-1981.
7. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43:1467-1472.
8. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 1993;342: 697-699.
9. Chartier-Harlin M-C, Parfitt M, Legrain S, et al. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease. Hum Mol Genet. 1994;3:569-574.
10. Okuizumi K, Onodera O, Tanaka H, et al. ApoE-epsilon 4 and early-onset Alzheimer's. Nat Genet. 1994;7:10-11.
11. van Duijn CM, de Knijff P, Cruts M, et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet. 1994;7: 74-78.
12. Nalbantoglu J, Gilfix BM, Bertrand P, et al. Predictive value of apolipoprotein E genotyping in Alzheimer's disease. Ann Neurol. 1994;36:889-895.
13. Roses AD, Devlin B, Conneally PM, et al. Measuring the genetic contribution of APOE in late-onset Alzheimer disease. Am J Hum Genet. 1995; 57:A202. Abstract.
14. Kukull WA, Schellenberg GD, Bowen JD, et al. Apolipoprotein E in Alzheimer's disease risk and case detection: a case-control study. J Clin Epidemiol. 1996;49:1143-1148.
15. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994;7:180-184.
16. Sorbi S, Nacmias B, Forleo P, et al. ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease. Neurosci Lett. 1994;177:100-102.
17. van Duijn CM, de Knijff P, Wehnert A, et al. The apolipoprotein E ε2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann Neurol. 1995;37:605-610.
18. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921-923.
19. Borgaonkar DS, Schmidt LC, Martin SE, et al. Linkage of late-onset Alzheimer's disease with apolipoprotein E type 4 on chromosome 19. Lancet. 1993;342:625.
20. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease. Neuron. 1993;11:575-580.
21. Strittmatter WJ, Saunders AM, Goedert M, et al. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau. Proc Natl Acad Sci U S A. 1994;91:11183-11186.
22. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 1994;17:525-530.
23. Zhou Z, Smith JD, Greengard P, Gandy S. Alzheimer amyloid-β peptide forms denaturant-resistant complex with type ε3 but not type ε4 isoform of native apolipoprotein E. Mol Med. 1996;2: 175-180.
24. Myers RH, Schaefer EJ, Wilson PWF, et al. Apolipoprotein E ε4 association with dementia in a population based study: the Framingham Study. Neurology. 1996;46:673-677.
25. Henderson AS, Easteal S, Jorm AF, et al. Apolipoprotein E allele ε4, dementia, and cognitive decline in a population sample. Lancet. 1995;346:1387-1390.
26. Farrer LA, Cupples LA, van Duijn CM, et al. Apolipoprotein E genotype in patients with Alzheimer disease. Ann Neurol. 1995;38:797-808.
27. Payami H, Montee KR, Kaye JA, et al. Alzheimer's disease, apolipoprotein E4, and gender. JAMA. 1994;271:1316-1317.
28. Mayeux R, Ottman R, Maestre G, et al. Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease. Neurology. 1995;45:565-557.
29. van Duijn CM, Havekes LM, Van Broeckhoven C, de Knijff P, Hofman A. Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease. BMJ. 1995;310:627-631.
30. Jarvik GP, Wijsman EM, Kukull WA, Schellenberg GD, Yu C, Larson EB. Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study. Neurology. 1995;45:1092-1096.
31. Van Duijn CM, Meijer H, Witteman JCM, et al. Estrogen apolipoprotein E and the risk of Alzheimer's disease. Neurobiol Aging. 1996;17(suppl):S79. Abstract.
32. Rebeck GW, Perls TT, West HL, Sodhi P, Lipsitz LA, Hyman BT. Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology. 1994;44:1513-1516.
33. Sobel E, Louhija J, Sulkava R, et al. Lack of association of apolipoprotein E allele ε4 with late-onset Alzheimer disease among Finnish centenarians. Neurology. 1995;45:903-907.
34. Corder EH, Basun H, Lannfelt L, Vitanen M, Winblad B. Attenuation of apolipoprotein E ε4 allele gene dose in late age. Lancet. 1996;347:542.
35. Maestre G, Ottman R, Stern Y, et al. Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol. 1995;37:254-259.
36. Hendrie HC, Hall KS, Hui S, et al. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Ann Neurol. 1995;37:118-120.
37. Osuntokun BO, Sahota A, Ogunniyi AO, et al. Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians. Ann Neurol. 1995;38:463-465.
38. Khachaturian Z. Diagnosis of Alzheimer's disease. Arch Neurol. 1985;42:1097-1105.
39. Benjamin R, Leake A, Ince PG, et al. Effects of apolipoprotein E genotype on cortical neuropathology in senile dementia of the Lewy Body and Alzheimer's disease. Neurodegeneration. 1995;4:443-448.
40. Benjamin R, Leake A, McArthur FK, et al. Apolipoprotein E genotype and Alzheimer's disease in an elderly Norwegian cohort. Neurodegeneration. 1996;5:43-47.
41. Betard C, Robitaille Y, Gee M, et al. Apo E allele frequencies in Alzheimer's disease, Lewy body dementia, Alzheimer's disease with cerebrovascular disease and vascular dementia. Neuroreport. 1994; 5:1893-1896.
42. Blacker D, Haines JL, Rodes L, et al. ApoE-4 and age at onset of Alzheimer's disease: the NIMH Genetics Initiative. Neurology. 1997;48:139-147.
43. Duara R, Barker WW, Lopez-Alberola R, et al. Alzheimer's disease: interaction of apolipoprotein E genotype, family history of dementia, gender, education, ethnicity and age of onset. Neurology. 1996; 46:1575-1579.
44. Fallin D, Gauntlett AC, Scibelli P, et al. No association between the very low density lipoprotein receptor gene and late-onset Alzheimer's disease and no interaction with the apolipoprotein E gene in population-based and clinic samples. Genet Epidemiol. 1997;14:299-305.
45. Frisoni GB, Calabresi L, Geroldi C, et al. Apolipoprotein E epsilon 4 allele in Alzheimer's disease and vascular dementia. Dementia. 1994;5:240-242.
46. Galasko D, Saitoh T, Xia Y, et al. The apolipoprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology. 1994;44:1950-1951.
47. Gearing M, Schneider JA, Rebeck GW, Hyman BT, Mirra S. Alzheimer's disease with and without co-existing Parkinson's disease changes. Neurology. 1995;45:1985-1990.
48. Harrington CR, Louwagie J, Rossau R, et al. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Am J Pathol. 1994;145:1472-1484.
49. Houlden H, Crook R, Hardy J, Roques P, Collinge J, Rossor M. Confirmation that familial clustering and age of onset in late onset Alzheimer's disease are determined at the apolipoprotein E locus. Neurosci Lett. 1994;174:222-224.
50. Kawamata J, Tanaka S, Shimohama S, Ueda K, Kimura J. Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia. J Neurol Neurosurg Psychiatry. 1994;57: 1414-1416.
51. Kurz A, Lautenschlager N, Haupt M, et al. The apolipoprotein E-epsilon 4 allele is a risk factor for Alzheimer disease with early and late onset. Nervenarzt. 1994;65:774-779.
52. Kuusisto J, Koivisto K, Kervinen K, et al. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. BMJ. 1994;309:636-638.
53. Lehtimaki T, Pirttila T, Mehta PD, Wisniewski HM, Frey H, Nikkari T. Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease. Hum Genet. 1995;95:39-42.
54. Lehtovirta M, Helisalmi S, Mannermaa A, et al. Apolipoprotein E polymorphism and Alzheimer's disease in eastern Finland. Neurosci Lett. 1995;185:13-15.
55. Lippa CF, Smith TW, Saunders AM, et al. Apolipoprotein E genotype and Lewy body disease. Neurology. 1995;45:97-103.
56. Lucotte G, Visvikis S, Leininger-Müler B, et al. Association of apolipoprotein E allele ε4 with late-onset sporadic Alzheimer's disease. Am J Med Genet. 1994;54:286-288.
57. Mahieux F, Couderc R, Moulignier A, Bailleul S, Podrabinek N, Laudet J. Isoforme 4 de l'apolipoproteine E et maladie d'Alzheimer. Rev Neurol. 1995;151:231-239.
58. Martins RN, Clarnette R, Fisher C, et al. ApoE genotypes in Australia. Neuroreport. 1995;6:1513-1516.
59. Noguchi S, Murakami K, Yamada M. Apolipoprotein E genotype and Alzheimer's disease. Lancet. 1993;342:737.
60. Pickering-Brown S, Mann DMA, Bourke JP, et al. Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other β-amyloid-forming diseases. Lancet. 1994;343:1155.
61. Smith AD, Johnston C, Sim E, et al. Protective effect of apoE ε2 in Alzheimer's disease. Lancet. 1994;344:473-474.
62. Smith AD, Jobst KA, Johnston C, Joachim C, Nagy Z. Apolipoprotein-E genotyping in diagnosis of Alzheimer's disease. Lancet. 1996;348:483-484.
63. St Clair D, Rennie M, Slorach E, Norrman J, Yates C, Carothers A. Apolipoprotein E 4 allele is a risk factor for familial and sporadic presenile Alzheimer's disease in both homozygote and heterozygote carriers. J Med Genet. 1995;32:642-644.
64. Talbot C, Lendon C, Craddock N, Shears S, Morris JC, Goate A. Protection against Alzheimer's disease with apoE epsilon 2. Lancet. 1994;343:1432-1433.
65. Tsai MS, Tangalos EG, Petersen RC, et al. Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet. 1994;54:643-649.
66. Ueki A, Kawano M, Namba Y, Kawakami M, Ikeda K. A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease. Neurosci Lett. 1993;163: 166-168.
67. Yoshizawa T, Yamakawa-Kobayashi K, Komatsuzaki Y, et al. Dose-dependent association of apolipoprotein E allele epsilon 4 with late-onset, sporadic Alzheimer's disease. Ann Neurol. 1994;36:656-659.
68. Zubenko GS, Stiffler S, Stabler S, et al. Association of the apolipoprotein E epsilon 4 allele with clinical subtypes of autopsy-confirmed Alzheimer's disease. Am J Med Genet. 1994;54:199-205.
69. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
70. Ordovas JM, Litwack-Klein L, Wilson PWF, Schaefer MM, Schaefer E. Apolipoprotein E isoform phenotyping methodology and population frequency with identification of APOE1 and APOE5 isoforms. J Lipid Res. 1987;28:371-380.
71. Wenham PR, Price WH, Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet. 1991;337:1158-1159.
72. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res. 1990;31:545-548.
73. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-748.
74. Breslow NE, Day NE. Statistical Methods in Cancer Research, Vol 1: The Analysis of Case-Control Studies. Lyon, France: International Agency for Research on Cancer; 1980. Publication 32.
75. Breslow NE, Day NE, Halvorsen KT, Prentice RL, Sabai C. Estimation of multiple relative risk functions in matched case-control studies. Am J Epidemiol. 1978;108:299-307.
76. SAS Institute. SAS User's Guide: Statistics. Cary, NC: SAS Institute Inc; 1990.
77. Dai XY, Nanko S, Hattori M, et al. Association of apolipoprotein E4 with sporadic Alzheimer's disease is more pronounced in early onset type. Neurosci Lett. 1994;175:74-76.
78. Bickeböller H, Campion D, Brice A, et al. Apolipoprotein E and Alzheimer disease. Am J Hum Genet. 1997;60:439-446.
79. Lautenschlager NT, Cupples LA, Rao VS, et al. Risk of dementia among relatives of Alzheimer disease patients in the MIRAGE study. Neurology. 1996;46:641-650.
80. Corder EH, Saunders AM, Strittmatter WJ, et al. The apolipoprotein E ε4 allele and sex-specific risks of Alzheimer's disease. JAMA. 1995;273:373-374.
81. Rao VS, Cupples LA, van Duijn CM, et al. Evidence for major gene inheritance of Alzheimer disease in families of patients with and without Apoe 4. Am J Hum Genet. 1996;59:664-675.
82. Tang M-X, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 1996;348:429-432.
83. Lannfelt L, Lilius L, Nastase M, et al. Lack of association between apolipoprotein E allele 4 and sporadic Alzheimer's disease. Neurosci Lett. 1994; 169:175-178.
84. Saunders AM, Hulette C, Welsh-Bohmer KA, et al. Specificity, sensitivity and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet. 1996;348:90-93.
85. Kakulas BA, Wilston SD, Fabian VA, Jones TM. Apolipoprotein-E genotyping in diagnosis of Alzheimer's disease. Lancet. 1996;348:483.